Skip to content
10-Q

Quarterly Report

HUBEI MINKANG PHARMACEUTICAL LTD.

0001477932-14-004457

← back to feed
Filed
Aug 14, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2014 · Aug 12, 2014 52.19M sh
Operating Cash Flow Q2 2014 · Jun 30, 2014 −$553.89K
Operating Cash Flow Q2 2014 · Jun 30, 2013 −$527.87K
Stockholders Equity Q2 2014 · Jun 30, 2014 $10.62M
Stockholders Equity Q2 2014 · Dec 31, 2013 $11.43M
Stockholders Equity Q2 2014 · Dec 31, 2012 $10.95M
Current Liabilities Q2 2014 · Jun 30, 2014 $9.25M
Current Liabilities Q2 2014 · Dec 31, 2013 $10.19M
Total Liabilities Q2 2014 · Jun 30, 2014 $9.25M
Total Liabilities Q2 2014 · Dec 31, 2013 $10.19M
Current Assets Q2 2014 · Jun 30, 2014 $13.22M
Current Assets Q2 2014 · Dec 31, 2013 $14.6M
Total Assets Q2 2014 · Jun 30, 2014 $19.87M
Total Assets Q2 2014 · Dec 31, 2013 $21.62M
Sga Expense Q2 2014 · Jun 30, 2014 $705.39K
Sga Expense Q2 2014 · Jun 30, 2014 $1.4M
Sga Expense Q2 2014 · Jun 30, 2013 $742.09K
Sga Expense Q2 2014 · Jun 30, 2013 $1.49M
Rd Expense Q2 2014 · Jun 30, 2014 $21.22K
Rd Expense Q2 2014 · Jun 30, 2014 $30.43K
Rd Expense Q2 2014 · Jun 30, 2013 $10.15K
Rd Expense Q2 2014 · Jun 30, 2013 $21.47K
Net Income Q2 2014 · Jun 30, 2014 −$645.07K
Net Income Q2 2014 · Jun 30, 2014 −$727.36K
Net Income Q2 2014 · Dec 31, 2013 $127.27K
Net Income Q2 2014 · Jun 30, 2013 $229.85K
Net Income Q2 2014 · Jun 30, 2013 −$56.39K
Operating Income Q2 2014 · Jun 30, 2014 −$589.9K
Operating Income Q2 2014 · Jun 30, 2014 −$686.65K
Operating Income Q2 2014 · Jun 30, 2013 −$35.97K
Operating Income Q2 2014 · Jun 30, 2013 −$286.05K
Gross Profit Q2 2014 · Jun 30, 2014 $534.83K
Gross Profit Q2 2014 · Jun 30, 2014 $1.74M
Gross Profit Q2 2014 · Jun 30, 2013 $1.5M
Gross Profit Q2 2014 · Jun 30, 2013 $2.62M
Revenue Q2 2014 · Jun 30, 2014 $1.68M
Revenue Q2 2014 · Jun 30, 2014 $4.57M
Revenue Q2 2014 · Jun 30, 2013 $3.95M
Revenue Q2 2014 · Jun 30, 2013 $6.68M
Cash And Equivalents Q2 2014 · Dec 31, 2013 $6.23M
Cash And Equivalents Q2 2014 · Dec 31, 2012 $6.07M
Capex Q2 2014 · Jun 30, 2013 $166.47K